최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecular neurobiology, v.49 no.1, 2014년, pp.39 - 49
Lee, Jung Hoon , Jiang, Yanxialei , Han, Dong Hoon , Shin, Seung Kyun , Choi, Won Hoon , Lee, Min Jae
The significantly higher incidence of Alzheimer's disease (AD) in women than in men has been attributed to loss of estrogen and a variety of related mechanisms at the molecular, cellular, and hormonal levels, which subsequently elucidate neuroprotective roles of estrogen against AD-related pathology...
Proc Natl Acad Sci USA C Corpechot 78 8 4704 1981 10.1073/pnas.78.8.4704 Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 78(8):4704-4707
Mol Cell Endocrinol Y Hojo 290 1-2 31 2008 10.1016/j.mce.2008.04.017 Hojo Y, Murakami G, Mukai H, Higo S, Hatanaka Y, Ogiue-Ikeda M, Ishii H, Kimoto T, Kawato S (2008) Estrogen synthesis in the brain-role in synaptic plasticity and memory. Mol Cell Endocrinol 290(1-2):31-43
J Alzheimers Dis W Wharton 26 3 495 2011 10.3233/JAD-2011-110341 Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S (2011) Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. J Alzheimers Dis 26(3):495-505
Science CM Revankar 307 5715 1625 2005 10.1126/science.1106943 Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307(5715):1625-1630
PLoS Med F Bunn 9 10 e1001331 2012 10.1371/journal.pmed.1001331 Bunn F, Goodman C, Sworn K, Rait G, Brayne C, Robinson L, McNeilly E, Iliffe S (2012) Psychosocial factors that shape patient and carer experiences of dementia diagnosis and treatment: a systematic review of qualitative studies. PLoS Med 9(10):e1001331
Physiol Rev DJ Selkoe 81 2 741 2001 10.1152/physrev.2001.81.2.741 Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81(2):741-766
Alzheimers Res Ther PS Aisen 1 1 2 2009 10.1186/alzrt2 Aisen PS (2009) Alzheimer's disease therapeutic research: the path forward. Alzheimers Res Ther 1(1):2
Prog Neurobiol MJ Lee 105 2013 49 2013 Lee MJ, Lee JH, Rubinsztein DC (2013) Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105(2013):49-59
Neurology P Giannakopoulos 60 9 1495 2003 10.1212/01.WNL.0000063311.58879.01 Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, Morrison JH, Gold G, Hof PR (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60(9):1495-1500
Cancer Treat Rev JF Robertson 30 8 695 2004 10.1016/j.ctrv.2004.04.003 Robertson JF (2004) Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective. Cancer Treat Rev 30(8):695-706
Oncologist DB Muchmore 5 5 388 2000 10.1634/theoncologist.5-5-388 Muchmore DB (2000) Raloxifene: a selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist 5(5):388-392
Endocr Rev WB Pratt 18 3 306 1997 Pratt WB, Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18(3):306-360
Nat Rev Drug Discov H Gronemeyer 3 11 950 2004 10.1038/nrd1551 Gronemeyer H, Gustafsson JA, Laudet V (2004) Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3(11):950-964
J Biol Chem C Rochette-Egly 280 38 32565 2005 10.1074/jbc.R500008200 Rochette-Egly C (2005) Dynamic combinatorial networks in nuclear receptor-mediated transcription. J Biol Chem 280(38):32565-32568
Mol Endocrinol JS Carroll 20 8 1707 2006 10.1210/me.2005-0334 Carroll JS, Brown M (2006) Estrogen receptor target gene: an evolving concept. Mol Endocrinol 20(8):1707-1714
Biochim Biophys Acta V Okoh 1815 1 115 2011 Okoh V, Deoraj A, Roy D (2011) Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta 1815(1):115-133
Mol Endocrinol L Bjornstrom 19 4 833 2005 10.1210/me.2004-0486 Bjornstrom L, Sjoberg M (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19(4):833-842
Mol Endocrinol EJ Filardo 16 1 70 2002 10.1210/mend.16.1.0758 Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI (2002) Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16(1):70-84
J Physiol Pharmacol E Filice 60 4 3 2009 Filice E, Recchia AG, Pellegrino D, Angelone T, Maggiolini M, Cerra MC (2009) A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat. J Physiol Pharmacol 60(4):3-10
Mol Endocrinol EJ Filardo 14 10 1649 2000 10.1210/mend.14.10.0532 Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14(10):1649-1660
Endocrinology P Thomas 146 2 624 2005 10.1210/en.2004-1064 Thomas P, Pang Y, Filardo EJ, Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146(2):624-632
Br J Pharmacol CM Doolan 129 7 1375 2000 10.1038/sj.bjp.0703193 Doolan CM, Condliffe SB, Harvey BJ (2000) Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon. Br J Pharmacol 129(7):1375-1386
Front Neuroendocrinol N Vasudevan 29 2 238 2008 10.1016/j.yfrne.2007.08.003 Vasudevan N, Pfaff DW (2008) Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front Neuroendocrinol 29(2):238-257
Ann N Y Acad Sci EH Corder 1019 24 2004 10.1196/annals.1297.005 Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24-28
Arch Gen Psychiatry LL Barnes 62 6 685 2005 10.1001/archpsyc.62.6.685 Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62(6):685-691
Eur J Neurosci G Kalesnykas 21 5 1437 2005 10.1111/j.1460-9568.2005.03953.x Kalesnykas G, Roschier U, Puolivali J, Wang J, Miettinen R (2005) The effect of aging on the subcellular distribution of estrogen receptor-alpha in the cholinergic neurons of transgenic and wild-type mice. Eur J Neurosci 21(5):1437-1442
Neuroscience PJ Shughrue 96 1 41 2000 10.1016/S0306-4522(99)00520-5 Shughrue PJ, Scrimo PJ, Merchenthaler I (2000) Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain. Neuroscience 96(1):41-49
Prog Neurobiol LM Garcia-Segura 63 1 29 2001 10.1016/S0301-0082(00)00025-3 Garcia-Segura LM, Azcoitia I, DonCarlos LL (2001) Neuroprotection by estradiol. Prog Neurobiol 63(1):29-60
Endocrinology JJ Watters 138 9 4030 1997 10.1210/endo.138.9.5489 Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138(9):4030-4033
Endocrine M Singh 14 3 407 2001 10.1385/ENDO:14:3:407 Singh M (2001) Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 14(3):407-415
J Neurosci CA Singer 19 7 2455 1999 10.1523/JNEUROSCI.19-07-02455.1999 Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19(7):2455-2463
J Neurochem M Cordey 84 6 1340 2003 10.1046/j.1471-4159.2003.01631.x Cordey M, Gundimeda U, Gopalakrishna R, Pike CJ (2003) Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem 84(6):1340-1348
J Neurosci M Yao 27 6 1422 2007 10.1523/JNEUROSCI.2382-06.2007 Yao M, Nguyen TV, Pike CJ (2007) Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death. J Neurosci 27(6):1422-1433
J Neurochem CJ Pike 72 4 1552 1999 10.1046/j.1471-4159.1999.721552.x Pike CJ (1999) Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72(4):1552-1563
Int J Dev Neurosci H Shy 18 2-3 289 2000 10.1016/S0736-5748(99)00097-0 Shy H, Malaiyandi L, Timiras PS (2000) Protective action of 17beta-estradiol and tamoxifen on glutamate toxicity in glial cells. Int J Dev Neurosci 18(2-3):289-297
Endocrinology SF Spampinato 153 12 5940 2012 10.1210/en.2012-1799 Spampinato SF, Merlo S, Molinaro G, Battaglia G, Bruno V, Nicoletti F, Sortino MA (2012) Dual effect of 17beta-estradiol on NMDA-induced neuronal death: involvement of metabotropic glutamate receptor 1. Endocrinology 153(12):5940-5948
J Neurosci JC Carroll 27 48 13357 2007 10.1523/JNEUROSCI.2718-07.2007 Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27(48):13357-13365
Endocrinology P Luciani 149 9 4256 2008 10.1210/en.2007-1795 Luciani P, Deledda C, Rosati F, Benvenuti S, Cellai I, Dichiara F, Morello M, Vannelli GB, Danza G, Serio M, Peri A (2008) Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology 149(9):4256-4266
Proc Natl Acad Sci USA X Yue 102 52 19198 2005 10.1073/pnas.0505203102 Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R (2005) Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA 102(52):19198-19203
Ann N Y Acad Sci R Marin 1007 108 2003 10.1196/annals.1286.011 Marin R, Guerra B, Morales A, Diaz M, Alonso R (2003) An ICI 182,780-sensitive, membrane-related estrogen receptor contributes to estrogenic neuroprotective actions against amyloid-beta toxicity. Ann N Y Acad Sci 1007:108-116
J Neurochem JL Fitzpatrick 82 3 674 2002 10.1046/j.1471-4159.2002.01000.x Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM (2002) Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J Neurochem 82(3):674-682
Neurodegener Dis LC Nord 7 6 349 2010 10.1159/000282279 Nord LC, Sundqvist J, Andersson E, Fried G (2010) Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells. Neurodegener Dis 7(6):349-364
Neurobiol Aging L Zhao 32 11 1949 2011 10.1016/j.neurobiolaging.2009.12.010 Zhao L, Yao J, Mao Z, Chen S, Wang Y, Brinton RD (2011) 17beta-Estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging 32(11):1949-1963
J Biol Chem K Liang 285 2 935 2010 10.1074/jbc.M109.051664 Liang K, Yang L, Yin C, Xiao Z, Zhang J, Liu Y, Huang J (2010) Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J Biol Chem 285(2):935-942
Mol Cell Biol J Bao 27 4 1321 2007 10.1128/MCB.01280-06 Bao J, Cao C, Zhang X, Jiang F, Nicosia SV, Bai W (2007) Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol Cell Biol 27(4):1321-1333
Biochim Biophys Acta C Shi 1820 4 453 2012 10.1016/j.bbagen.2011.12.005 Shi C, Zheng DD, Fang L, Wu F, Kwong WH, Xu J (2012) Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. Biochim Biophys Acta 1820(4):453-460
Neurosci Lett HG Bernstein 263 2-3 161 1999 10.1016/S0304-3940(99)00135-4 Bernstein HG, Ansorge S, Riederer P, Reiser M, Frolich L, Bogerts B (1999) Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci Lett 263(2-3):161-164
Trends Biochem Sci IV Kurochkin 26 7 421 2001 10.1016/S0968-0004(01)01876-X Kurochkin IV (2001) Insulin-degrading enzyme: embarking on amyloid destruction. Trends Biochem Sci 26(7):421-425
FEBS Lett IV Kurochkin 345 1 33 1994 10.1016/0014-5793(94)00387-4 Kurochkin IV, Goto S (1994) Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345(1):33-37
Neurobiol Aging WQ Qiu 27 2 190 2006 10.1016/j.neurobiolaging.2005.01.004 Qiu WQ, Folstein MF (2006) Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging 27(2):190-198
Endocrinology A Jayaraman 153 11 5467 2012 10.1210/en.2012-1464 Jayaraman A, Carroll JC, Morgan TE, Lin S, Zhao L, Arimoto JM, Murphy MP, Beckett TL, Finch CE, Brinton RD, Pike CJ (2012) 17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology 153(11):5467-5479
Am J Pathol W Farris 171 1 241 2007 10.2353/ajpath.2007.070105 Farris W, Schutz SG, Cirrito JR, Shankar GM, Sun X, George A, Leissring MA, Walsh DM, Qiu WQ, Holtzman DM, Selkoe DJ (2007) Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol 171(1):241-251
J Mol Neurosci ZM Xiao 39 1-2 22 2009 10.1007/s12031-008-9168-1 Xiao ZM, Sun L, Liu YM, Zhang JJ, Huang J (2009) Estrogen regulation of the neprilysin gene through a hormone-responsive element. J Mol Neurosci 39(1-2):22-26
J Neurosci KJ Yin 26 43 10939 2006 10.1523/JNEUROSCI.2085-06.2006 Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 26(43):10939-10948
Biochim Biophys Acta CS Wingrove 1406 2 169 1998 10.1016/S0925-4439(97)00097-5 Wingrove CS, Garr E, Godsland IF, Stevenson JC (1998) 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1406(2):169-174
Mol Cell Neurosci S Merlo 49 4 423 2012 10.1016/j.mcn.2012.02.005 Merlo S, Sortino MA (2012) Estrogen activates matrix metalloproteinases-2 and −9 to increase beta amyloid degradation. Mol Cell Neurosci 49(4):423-429
Neuroscience S Goodenough 132 3 581 2005 10.1016/j.neuroscience.2004.12.029 Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C (2005) Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience 132(3):581-589
J Neurosci QG Zhang 28 34 8430 2008 10.1523/JNEUROSCI.2752-08.2008 Zhang QG, Wang R, Khan M, Mahesh V, Brann DW (2008) Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci 28(34):8430-41
Neurochem Res XA Liu 33 9 1811 2008 10.1007/s11064-008-9638-4 Liu XA, Zhu LQ, Zhang Q, Shi HR, Wang SH, Wang Q, Wang JZ (2008) Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A. Neurochem Res 33(9):1811-1820
J Neurosci S Wray 29 31 9665 2009 10.1523/JNEUROSCI.2234-09.2009 Wray S, Noble W (2009) Linking amyloid and tau pathology in Alzheimer's disease: the role of membrane cholesterol in Abeta-mediated tau toxicity. J Neurosci 29(31):9665-9667
Mol Pharmacol SF Spampinato 81 1 12 2012 10.1124/mol.111.074021 Spampinato SF, Molinaro G, Merlo S, Iacovelli L, Caraci F, Battaglia G, Nicoletti F, Bruno V, Sortino MA (2012) Estrogen receptors and type 1 metabotropic glutamate receptors are interdependent in protecting cortical neurons against beta-amyloid toxicity. Mol Pharmacol 81(1):12-20
J Clin Endocrinol Metab S Benvenuti 90 3 1775 2005 10.1210/jc.2004-0066 Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Franceschi E, Serio M, Peri A (2005) Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. J Clin Endocrinol Metab 90(3):1775-1782
Curr Alzheimer Res JF Kelly 5 1 45 2008 10.2174/156720508783884611 Kelly JF, Bienias JL, Shah A, Meeke KA, Schneider JA, Soriano E, Bennett DA (2008) Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. Curr Alzheimer Res 5(1):45-51
J Clin Endocrinol Metab A Hestiantoro 89 4 1912 2004 10.1210/jc.2003-030862 Hestiantoro A, Swaab DF (2004) Changes in estrogen receptor-alpha and -beta in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology. J Clin Endocrinol Metab 89(4):1912-1925
Endocrinology JC Carroll 149 5 2607 2008 10.1210/en.2007-1346 Carroll JC, Pike CJ (2008) Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 149(5):2607-2611
Neurobiol Learn Mem M Bagheri 95 3 270 2011 10.1016/j.nlm.2010.12.001 Bagheri M, Joghataei MT, Mohseni S, Roghani M (2011) Genistein ameliorates learning and memory deficits in amyloid beta(1-40) rat model of Alzheimer's disease. Neurobiol Learn Mem 95(3):270-276
Mol Neurobiol A Grimm 46 1 151 2012 10.1007/s12035-012-8281-x Grimm A, Lim YA, Mensah-Nyagan AG, Gotz J, Eckert A (2012) Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship. Mol Neurobiol 46(1):151-160
Neurology H Shao 79 18 1846 2012 10.1212/WNL.0b013e318271f823 Shao H, Breitner JC, Whitmer RA, Wang J, Hayden K, Wengreen H, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP (2012) Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 79(18):1846-1852
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.